COSIRA
COronary SInus
Reducer for
Treatment of
Refractory Angina
Positive results from the COSIRA clinical trial assessing the
efficacy and safety of the Neovasc Reducer published
in The New England Journal of Medicine.
LEARN MORE
reducer™
A novel device for the
treatment of Refractory Angina
Potential relief of symptoms
for those suffering from
persistent angina pain
LEARN MORE
tiara™
Minimally invasive
treatment for a
common form
of mitral valve
disease
Potential new therapeutic option
for millions of patients
LEARN MORE
Unmet Need in Treating Patients
Suffering from Refractory Angina
The Neovasc Presentation from this year's
TCT Connect Virtual Conference, held October 14-18, 2020
WATCH HERE
